Loading clinical trials...
Loading clinical trials...
Primary objective: To assess and compare the toxicities of patients with advanced NPC treated with concurrent cisplatin-radiotherapy with or without neoadjuvant Taxotere (docetaxel) and cisplatin. S...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Sanofi
NCT07326358 · Nasopharyngeal Neoplasms, Laryngeal Disease
NCT05807880 · Nasopharyngeal Neoplasms
NCT02611960 · Nasopharyngeal Neoplasms
NCT00342147 · Nasopharyngeal Neoplasms, Herpesvirus 4, Human
NCT00393224 · Nasopharyngeal Neoplasms
Sanofi-Aventis
Hong Kong
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions